Hiltunen M - Search Results

1

Genetic risk factors in Finnish patients with Parkinson's disease.

Ylönen S, Siitonen A, Nalls MA, Ylikotila P, Autere J, Eerola-Rautio J, Gibbs R, Hiltunen M, Tienari PJ, Soininen H, Singleton AB, Majamaa K. Ylönen S, et al. Among authors: hiltunen m. Parkinsonism Relat Disord. 2017 Dec;45:39-43. doi: 10.1016/j.parkreldis.2017.09.021. Epub 2017 Sep 29. Parkinsonism Relat Disord. 2017. PMID: 29029963 Free PMC article.

2

Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.

Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynänen M, Riekkinen P Sr, Soininen H. Hiltunen M, et al. Neurosci Lett. 1998 Jun 26;250(1):69-71. doi: 10.1016/s0304-3940(98)00453-4. Neurosci Lett. 1998. PMID: 9696068

3

Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients.

Hiltunen M, Mannermaa A, Koivisto AM, Lehtovirta M, Helisalmi S, Ryynänen M, Riekkinen P Sr, Soininen H. Hiltunen M, et al. Eur J Hum Genet. 1999 Sep;7(6):652-8. doi: 10.1038/sj.ejhg.5200342. Eur J Hum Genet. 1999. PMID: 10482953

4

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. J Neurol. 1999 Sep;246(9):821-4. doi: 10.1007/s004150050461. J Neurol. 1999. PMID: 10525981 Clinical Trial.

5

Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease?

Helisalmi S, Hiltunen M, Mannermaa A, Koivisto AM, Lehtovirta M, Alafuzoff I, Ryynänen M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. Neurosci Lett. 2000 Jan 7;278(1-2):65-8. doi: 10.1016/s0304-3940(99)00891-5. Neurosci Lett. 2000. PMID: 10643802

6

The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E.

Helisalmi S, Valve R, Karvonen MK, Hiltunen M, Pirskanen M, Mannermaa A, Koulu M, Pesonen U, Uusitupa M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. Neurosci Lett. 2000 Jun 16;287(1):25-8. doi: 10.1016/s0304-3940(00)01126-5. Neurosci Lett. 2000. PMID: 10841982

7

Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?

Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M, Pirskanen M, Sulkava R, Verkkoniemi A, Soininen H. Hiltunen M, et al. Eur J Hum Genet. 2000 Apr;8(4):259-66. doi: 10.1038/sj.ejhg.5200423. Eur J Hum Genet. 2000. PMID: 10854108

8

MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.

Reynolds WF, Hiltunen M, Pirskanen M, Mannermaa A, Helisalmi S, Lehtovirta M, Alafuzoff I, Soininen H. Reynolds WF, et al. Among authors: hiltunen m. Neurology. 2000 Nov 14;55(9):1284-90. doi: 10.1212/wnl.55.9.1284. Neurology. 2000. PMID: 11087769

9

An association between a subset of Finnish late-onset Alzheimer's disease and alpha2-macroglobulin.

Pirskanen M, Alafuzoff I, Hiltunen M, Mannermaa A, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M, Soininen H. Pirskanen M, et al. Among authors: hiltunen m. Neurogenetics. 2001 Jul;3(3):171-2. doi: 10.1007/s100480100110. Neurogenetics. 2001. PMID: 11523569 No abstract available.

10

Genes, proteins and brain disease.

Hiltunen M, Soininen H. Hiltunen M, et al. Trends Mol Med. 2001 Sep;7(9):382-3. doi: 10.1016/s1471-4914(01)02098-6. Trends Mol Med. 2001. PMID: 11530316 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

389 results

Search Page